Skip to content
healthcare.dev

Potassium Citrate

NDC 44523-415, potassium citrate, tablet, from Biocomp Pharma, Inc..

Product NDC
44523-415
Status
Listed
Labeler
Biocomp Pharma, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA019071
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/44523-415 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • POTASSIUM CITRATE15 meq/1

Pharmacologic classes

Acidifying Activity [MoA]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]; Calculi Dissolution Agent [EPC]; Decreased Coagulation Factor Activity [PE]

Package NDCNDC-11Package
44523-415-0144523041501100 TABLET in 1 BOTTLE (44523-415-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b32fe71a-4a58-04a1-64d3-bc3cc4a895bf
  • NADAC price for package 44523041501

    GET /v1/drugs/nadac/44523041501

Use it

Look up 44523-415 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/44523-415 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 44523-415. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.